Abstract
Plasma levels of gut-derived endotoxins (lipopolysaccharides, LPS) are often elevated in cirrhotics and are thought to contribute to hepatic encephalopathy. Circulating LPS activates macrophages to produce tumor necrosis factor ά (TNF-ά) and other potentially cytotoxic proinflammatory mediators. A pathogenic role forendotoxins is supported by studies showing that treatment with Lactobacillusor antibiotics, both of which reduce LPS-producingintestinal Gram-negative bacteria, alleviates experimental liver damage. To mimic the “leaky gut” syndrome with endotoxin translocation into the circulation in cirrhotics, a new animal model was developed. Rats were chronically exposed to ethanol and for the four last weeks also infused with endotoxin into the jugular vein from subcutaneously implanted osmotic minipumps. Animals receiving endotoxin had elevated hepatic expression of both pro- and anti-inflammatory cytokines, but compared to ethanol treatment alone hepatic steatosis and inflammatory changes were only marginally increased. This demonstrates marked endotoxin tolerance, probably as a consequence of a counteracting anti-inflammatory cytokine response. The role of gut-derived endotoxin in hepatic encephalopathy has recently received considerable attention. To further delineate the role and actions of endotoxin and its extrahepatic effects, studies applying both acute challenge and chronic infusion seem warranted. The chronic endotoxin model, mimicking the “leaky gut,” may best be combined with more robust ways to impair liver function, such as carbon tetrachloride treatment, bile duct ligation, or galactosamine administration.
Similar content being viewed by others
References
Adachi, Y., Moore, L.E., Bradford, B.U., Gao, W., and Thurman, R.G. (1995). Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218–224.
Ali, M.V., and Nolan, J.P. (1967). Alcohol induced depression of reticuloendothelial function in the rat. J. Lab. Clin. Med. 70:295–301.
Arai, T., Hiromatsu, K., Kobayashi, N., Takano, M., Ishida, H., Nimura, Y., and Yoshikai, Y. (1995). IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743–5749.
Bauer, T.M., Schwacha, H., Steinbruckner, B., Brinkmann, F.E., Ditzen, A.K., Aponte, J.J., Pelz, K., Berger, D., Kist, M., and Blum, H.E. (2002). Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am. J. Gastroenterol. 97:2364–2370.
Bickel, U., Grave, B., Kang, Y.S., del Rey, A., and Voigt, K. (1998). No increase in blood–brain barrier permeability after intraperitoneal injection of endotoxin in the rat. J. Neuroimmunol. 85:131–136.
Bigatello, L.M., Broitman, S.A., Fattori, L., Di Paoli, M., Pontello, M., Bevilacqua, G., and Nespoli, A. (1987). Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82:11–15.
Bjarnason, I., Peters, T.J., and Wise, R.J. (1984). The leaky gut of alcoholism: Possible route of entry for toxic compounds. Lancet 1(8370):179–182.
Bode, C., Kugler, V., and Bode, J.C.J. (1987). Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4:8–14.
Chiva, M., Soriano, G., Rochat, I., Peralta, C., Rochat, F., Llovet, T., Mirelis, B., Schiffrin, E.J., Guarner, C., and Balanzo, J. (2002). Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J. Hepatol. 37:456–462.
Clausen, M.R., and Mortensen, P.B. (1997). Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53:930–942.
de Vries, H.E., Blom-Roosemalen, M.C., van Oosten, M., de Boer, A.G., van Berkel, T.J., Breimer, D.D., and Kuiper, J. (1996). The influence of cytokines on the integrity of the blood–brain barrier in vitro. J. Neuroimmunol. 64:37–43.
Hagan, P., Poole, S., and Bristow, A.F. (1993). Endotoxin-stimulated production of rat hypothalamic interleukin 1β in vivo and in vitro, measured by specific immunoradiometric assay. J. Mol. Endocrinol. 11:31–36.
Hill, D.B., D'Souza, N.B., Lee, E.Y., Burikhanov, R., Deaciuc, I.V., and de Villiers, W.J. (2002). A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin. Exp. Res. 26:74–82.
Järveläinen, H.A., Fang, C., Ingelman-Sundberg, M., and Lindros, K.O. (1999). Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 29:1503–1510.
Järveläinen, H.A., Oinonen, T., and Lindros, K.O. (1997). Alcohol-induced expression of the CD14 endotoxin receptor protein in rat Kupffer cells. Alcohol Clin. Exp. Res. 21:1547–1551.
Järveläinen, H.A., Orpana, A., Perola, M., Savolainen, V.T., Karhunen, P.J., and Lindros, K.O. (2001). Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 33:1148–1153.
Lindros, K.O., and Järveläinen, H.A. (1998). A new oral low-carbohydrate alcohol liquid diet producing liver lesions: A preliminary account. Alcohol Alcohol. 33:347–353.
Liu, Q., Duan, Z.P., Ha, da K., Bengmark, S., Kurtovic, J., and Riordan, S.M. (2004). Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441–1449.
Mathurin, P., Deng, Q.G., Keshavarzian, A., Choudhary, S., Holmes, E.W., and Tsukamoto, H. (2000). Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32:1008–1017.
Nanji, A.A., Khettry, U., and Sadrzadeh, S.M. (1994). Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc. Soc. Exp. Biol. Med. 205:243–247.
Nayyar, R.P., Hurley, R.M., Goto, M., and Zeller, W.P. (1989). Microvascular endothelium: A major target site of endotoxin induced injury in 10 day old rat. J. Exp. Pathol. 4:57–67.
Nolan, J.P. (1989). Intestinal endotoxins as mediators of hepatic injury—an idea whose time has come again. Hepatology 10:887–891.
Odeh, M. (1994). Endotoxin and tumor necrosis factor-a in the pathogenesis of hepatic encephalopathy. J. Clin. Gastroenterol. 19:146–153.
Odeh, M., Sabo, E., Srugo, I., and Oliven, A. (2004). Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int. 24:110–116.
Redl, H., Bahrami, S., Schlag, G., and Traber, D.L. (1993). Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187:330–345.
Solga, S.F., and Diehl, A.M. (2004). Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 39:1197–1200.
Tamai, H., Horie, Y., Kato, S., Yokoyama, H., and Ishii, H. (2002). Long-term ethanol feeding enhances susceptibility of the liver to orally administered lipopolysaccharides in rats. Alcohol Clin. Exp. Res. 26:75S–80S.
Tarao, K., So, K., Moroi, T., Ikeuchi, T., and Suyama, T. (1977). Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance. Gastroenterology 73:539–542.
Triger, D.R., Boyer, T.D., and Levin, J. (1978). Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut 19:935–939.
Vilstrup, H. (2003). Cirrhosis and bacterial infections. Rom. J. Gastroenterol. 12:297–302.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lindros, K.O., Järveläinen, H.A. Chronic Systemic Endotoxin Exposure: An Animal Model in Experimental Hepatic Encephalopathy. Metab Brain Dis 20, 393–398 (2005). https://doi.org/10.1007/s11011-005-7924-2
Issue Date:
DOI: https://doi.org/10.1007/s11011-005-7924-2